
CAS 1338452-54-2
:EveroliMus-d4
Description:
EveroliMus-d4, with the CAS number 1338452-54-2, is a synthetic compound that is primarily used in research settings, particularly in studies involving pharmacology and biochemistry. As a deuterated analog of Everolimus, it features deuterium atoms replacing certain hydrogen atoms, which enhances its stability and allows for more precise tracking in metabolic studies. This modification can improve the compound's pharmacokinetic properties, making it useful for understanding drug metabolism and interactions. EveroliMus-d4 is often employed in mass spectrometry and other analytical techniques to differentiate between the compound and its non-deuterated counterparts. Its characteristics include a specific molecular structure that contributes to its biological activity, particularly in inhibiting the mTOR pathway, which is crucial in cell growth and proliferation. As with any chemical substance, handling and usage should adhere to safety protocols, and its applications are typically confined to controlled laboratory environments.
Formula:C53H79D4NO14
Synonyms:- Everolimus D4
- Everolimus D4Q: What is
- EveroliMus-d4 (~90%)
- Everolimus Impurity 24(Everolimus-d4)
- EVEROLIMUS (2-HYDROXYETHYL-D4, 98%)
- Everolimus D4 Q: What is the CAS Number of
- Everolimus D4 Q: What is the storage condition of
- Everolimus D4 Q: What are the applications of
- Everolimus-d4
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Everolimus-d4
CAS:Formula:C53H79D4NO14Color and Shape:White To Off-White SolidMolecular weight:962.26Everolimus-d4
CAS:<p>Everolimus-d4 is a deuterated compound of Everolimus.</p>Formula:C53H83NO14Color and Shape:SolidMolecular weight:962.264Everolimus-d4 (>85%)
CAS:Controlled Product<p>Applications Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Dumont, F.J., et al.: Curr. Opin. Invest. Drugs, 2, 1220 (2001), Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001), Nashan, B., et al.: Ther. Drug Monit., 24, 53 (2002),<br></p>Formula:C532H4H79NO14Purity:>85%Color and Shape:White To Light YellowMolecular weight:962.25Everolimus-d4 (~90%)
CAS:Formula:C53H79D4NO14Purity:98%Color and Shape:SolidMolecular weight:962.2491Ref: IN-DA01CB7W
Discontinued product



